newsfilter
← Latest News
GlobeNewswire·

Verve Therapeutics Announces Pipeline Progress and Reports First Quarter 2024 Financial Results

First patient dosed in Heart-2 Phase 1b clinical trial of VERVE-102 VERVE-201 clinical trial initiation on track for the second half of 2024 Received first milestone payment from Eli Lilly for collaboration on an in